Quantitative Emphysema on Low-Dose Computed Tomography of the Chest and Risk of Lung Cancer and Airflow Obstruction: An analysis of the National Lung Screening Trial

RECOMMENDED

Lung Cancer

Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial

Chest.

Whittaker Brown SA, Padilla M, Mhango G, Powell C, Salvatore M, Henschke C, Yankelevitz D, Sigel K, de-Torres JP, Wisnivesky J

doi: 10.1016/j.chest.

RECOMMENDED

Lung Cancer

Use of imaging and diagnostic procedures after low dose computed tomography screening for lung cancer

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Chest.

Nishi SPE, Zhou J, Okereke I, Kuo YF, Goodwin J

doi: 10.1016/j.chest.2019.08.2187.

RECOMMENDED

Lung Cancer

Patient-level trajectories and outcomes after low-dose CT screening in the National Lung Screening Trial

Chest.

Iaccarino JM, Silvestri GA, Wiener RS

doi: 10.1016/j.chest.2019.06.016.

RECOMMENDED

Emphysema

The effect of radiographic emphysema in assessing lung cancer risk

Thorax.

Yong PC, Sigel K, de-Torres JP, Mhango G, Kale M, Kong CY, Zulueta JJ, Wilson D, Brown SW, Slatore C, Wisnivesky J

doi: 10.1136/thoraxjnl-

RECOMMENDED

Lung Cancer

Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

J Clin Oncol

Passiglia F, Cinquini M, Bertolaccini L, Del Re M, Facchinetti F, Ferrara R, Franchina T, Larici AR, Malapelle U, Menis J, Passaro A, Pilotto S, Ramella S, Rossi G, Trisolini R, Novello S

doi: 10.1200/JCO.20.02574

RECOMMENDED

Lung Cancer

Analysis of lung cancer risk model (PLCO_M2012 and LLP_v2) performance in a community-based lung cancer screening programme

★ 2 Recommended by Dr Martin Frey, Faculty Member

Thorax.

Lebrett MB, Balata H, Evison M, Colligan D, Duerden R, Elton P, Greaves M, Howells J, Irion K, Karunaratne D, Lyons J, Mellor S, Myerscough A, Newton T, Sharman A, Smith E, Taylor B, Taylor S, Walsham A, Whittaker J, Barber PV, Tonge J, Robbins HA, Booton R, Crosbie PAJ

doi: 10.1136/thoraxjnl-2020-214626.

RECOMMENDED

Lung Cancer

Racial Differences in Adherence to Lung Cancer Screening Follow-Up: A Systematic Review and Meta-Analysis

★ 1 Recommended by Dr Martin Frey, Faculty Member

Chest

Kunitomo Y, Bade B, Gunderson CG, Akgün KM, Brackett A, Cain H, Tanoue L, Bastian LA

doi: 10.1016/j.chest.2021.07.2172

COPDLung Cancer

Features of Chronic Obstructive Pulmonary Disease as Predictors of Lung Cancer

Chest.

Carr LL, Jacobson S, Lynch DA, Foreman MG, Flenaugh EL, Hersh CP, Sciurba FC, Wilson DO, Sieren JC, Mulhall P, Kim V, Kinsey CM, Bowler RP

doi: 10.1016/j.chest.2018.01.049.

RECOMMENDED

COPD

Prevalence, Symptom Burden and Under-Diagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort

★ 1 Recommended by Dr Martin Frey, Faculty Member

Ann Am Thorac Soc.

Ruparel M, Quaife SL, Dickson JL, Horst C, Tisi S, Hall H, Taylor MN, Ahmed A, Shaw PJ, Burke S, Soo MJ, Nair A, Devaraj A, Sennett K, Hurst JR, Duffy SW, Navani N, Bhowmik A, Baldwin DR, Janes SM

doi: 10.1513/AnnalsATS.201911-857OC.

Related content

Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial

Use of imaging and diagnostic procedures after low dose computed tomography screening for lung cancer

Patient-level trajectories and outcomes after low-dose CT screening in the National Lung Screening Trial

The effect of radiographic emphysema in assessing lung cancer risk

Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis

Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme

Racial Differences in Adherence to Lung Cancer Screening Follow-Up: A Systematic Review and Meta-Analysis

Features of Chronic Obstructive Pulmonary Disease as Predictors of Lung Cancer

Prevalence, Symptom Burden and Under-Diagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort

Analysis of lung cancer risk model (PLCO_M2012 and LLP_v2) performance in a community-based lung cancer screening programme